Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1991;17:469-477

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsueh, W. A.
Right arrow Articles by Baxter, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsueh, W. A.
Right arrow Articles by Baxter, J. D.

Hypertension, Vol 17, 469-477, Copyright © 1991 by American Heart Association


ARTICLES

Human prorenin

WA Hsueh and JD Baxter
Department of Medicine, University of Southern California School of Medicine, Los Angeles 90033.

Human prorenin is the enzymatically inactive biosynthetic precursor of renin. Recent interest has focused on the posttranslational sorting and processing of prorenin to renin since markedly increased levels of circulating prorenin have been associated with both physiological and pathological changes. These observations raise the question of whether prorenin processing may be a regulatory event in renin production in the kidney. In the juxtaglomerular cells of the kidney, prorenin can be sorted to either of two pathways: 1) the regulated pathway, which is mediated by secretory granules, where a thiol protease resembling cathepsin B processes prorenin to renin by cleavage of the amino terminal 43-amino acid prosegment, which allows exposure of the active site of renin, or 2) the constitutive pathway, which is not regulated and does not involve conversion of prorenin to renin. Studies in which segments of prorenin are modified by site-directed mutagenesis suggest that the prosegment and glycosylation are not required for sorting, although they may influence or participate in sorting, or both. Certain areas in the prosegment are important determinants of enzyme activity and ability to cleave the prosegment. Further structural analysis of prorenin will be useful to assess details of its sorting and processing. In addition, a number of extrarenal tissues such as uterine lining, ovarian theca, corpus luteum, pituitary, and adrenal, express the renin gene. These tissues have different capabilities to sort and process prorenin compared with kidney, and some tissues secrete only prorenin. Whether prorenin-to-renin conversion is necessary to activate these local renin-angiotensin systems is a key issue.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
DiabetesHome page
J. L. Wilkinson-Berka and D. J. Campbell
(Pro)renin Receptor: A Treatment Target for Diabetic Retinopathy?
Diabetes, July 1, 2009; 58(7): 1485 - 1487.
[Full Text] [PDF]


Home page
HypertensionHome page
C. Mercure, G. Prescott, M.-J. Lacombe, D. W. Silversides, and T. L. Reudelhuber
Chronic Increases in Circulating Prorenin Are not Associated With Renal or Cardiac Pathologies
Hypertension, June 1, 2009; 53(6): 1062 - 1069.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Zhang, N. A. Noble, W. A. Border, R. T. Owens, and Y. Huang
Receptor-dependent prorenin activation and induction of PAI-1 expression in vascular smooth muscle cells
Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E810 - E819.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. J. Campbell
Critical Review of Prorenin and (Pro)renin Receptor Research
Hypertension, May 1, 2008; 51(5): 1259 - 1264.
[Full Text] [PDF]


Home page
J BiochemHome page
V. Laurent-Matha, D. Derocq, C. Prebois, N. Katunuma, and E. Liaudet-Coopman
Processing of human cathepsin d is independent of its catalytic function and auto-activation: involvement of cathepsins L and B.
J. Biochem., March 1, 2006; 139(3): 363 - 371.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Suzuki, M. Hayakawa, T. Nakagawa, U. M. Nasir, A. Ebihara, A. Iwasawa, Y. Ishida, Y. Nakamura, and K. Murakami
Human Prorenin Has "Gate and Handle" Regions for Its Non-proteolytic Activation
J. Biol. Chem., June 13, 2003; 278(25): 22217 - 22222.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. M. Carey and H. M. Siragy
Newly Recognized Components of the Renin-Angiotensin System: Potential Roles in Cardiovascular and Renal Regulation
Endocr. Rev., June 1, 2003; 24(3): 261 - 271.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Peters, R. Farrenkopf, S. Clausmeyer, J. Zimmer, S. Kantachuvesiri, M. G.F. Sharp, and J. J. Mullins
Functional Significance of Prorenin Internalization in the Rat Heart
Circ. Res., May 31, 2002; 90(10): 1135 - 1141.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. C. Almeida, V. Oliveira, J. R. Chagas, M. Meldal, M. A. Juliano, and L. Juliano
Hydrolysis by Cathepsin B of Fluorescent Peptides Derived From Human Prorenin
Hypertension, June 1, 2000; 35(6): 1278 - 1283.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Ichihara, H. Suzuki, Y. Miyashita, M. Naitoh, M. Hayashi, and T. Saruta
Transmural pressure inhibits prorenin processing in juxtaglomerular cell
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1999; 277(1): R220 - R228.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. Deinum, F. H.M. Derkx, and M. A.D.H. Schalekamp
Improved Immunoradiometric Assay for Plasma Renin
Clin. Chem., June 1, 1999; 45(6): 847 - 854.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. Methot, D. W. Silversides, and T. L. Reudelhuber
In Vivo Enzymatic Assay Reveals Catalytic Activity of the Human Renin Precursor in Tissues
Circ. Res., May 14, 1999; 84(9): 1067 - 1072.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. N. Muller, K. F. Hilgers, S. Mathews, V. Breu, W. Fischli, R. Uhlmann, and F. C. Luft
Effects of Human Prorenin in Rats Transgenic for Human Angiotensinogen
Hypertension, January 1, 1999; 33(1): 312 - 317.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
E. A. Karginova, E. S. Pentz, I. G. Kazakova, V. F. Norwood, R. M. Carey, and R. A. Gomez
Zis: a developmentally regulated gene expressed in juxtaglomerular cells
Am J Physiol Renal Physiol, November 1, 1997; 273(5): F731 - F738.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Methot, M. C. LaPointe, R. M. Touyz, X.-P. Yang, O. A. Carretero, C. F. Deschepper, E. L. Schiffrin, G. Thibault, and T. L. Reudelhuber
Tissue Targeting of Angiotensin Peptides
J. Biol. Chem., May 16, 1997; 272(20): 12994 - 12999.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Milsted, M. Nishimura, K. B. Brosnihan, and C. M. Ferrario
Differential Regulation of Angiotensinogen Transcripts After Renin Infusion
Hypertension, October 1, 1996; 28(4): 678 - 681.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C. Mercure, G. Thibault, S. Lussier-Cacan, J. Davignon, E. L. Schiffrin, and T. L. Reudelhuber
Molecular Analysis of Human Prorenin Prosegment Variants in Vitro and in Vivo
J. Biol. Chem., July 7, 1995; 270(27): 16355 - 16359.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. C. Fortenberry and J. M. Chirgwin
The Propeptide Is Nonessential for the Expression of Human Cathepsin D
J. Biol. Chem., April 28, 1995; 270(17): 9778 - 9782.
[Abstract] [Full Text] [PDF]